SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone SensitivityGunther Boysen, Johann S. de Bono, Mateus Crespo et al.|Clinical Cancer Research|2018Cited by 140
Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)Niven Mehra, Johann S. de Bono, David Dolling et al.|European Urology|2018Cited by 110
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNASemini Sumanasuriya, Johann S. de Bono, George Seed et al.|European Urology|2021Cited by 65